ReviewMolecular cancer2026
Non-coding RNAs: modulators of signaling pathways and prognostic biomarkers in digestive system cancer.
Review in Molecular cancer, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Digestive system cancer is one of the most lethal forms of aggressive cancer in the world. Although diagnosis and treatment methods have improved, most patients have poor survival expectations due to late detection and rapid disease progress. Some recent studies have delved into the molecular level of the mechanism of non-coding RNA (ncRNA) intervention in digestive system cancer and have conducted a more in-depth and comprehensive discussion. At the same time, it has also been shown that ncRNA plays an important role in early detection and targeted treatment of digestive system cancer. This review summarizes the roles of ncRNAs in modulating multiple key pathways, including Wnt/β-catenin and PI3K/AKT, thereby influencing diverse processes such as tumor proliferation, invasion, immune microenvironment remodeling, glycolytic metabolism, and macrophage polarization. Additionally, the prognostic significance of ncRNAs in digestive system cancers is summarized and appraised. According to the current review, ncRNA is expected to become a potential biological marker and intervention target for digestive system cancer, helping the treatment of digestive system cancer to move further towards precision medicine.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.